DE60006362D1 - Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen - Google Patents
Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungenInfo
- Publication number
- DE60006362D1 DE60006362D1 DE60006362T DE60006362T DE60006362D1 DE 60006362 D1 DE60006362 D1 DE 60006362D1 DE 60006362 T DE60006362 T DE 60006362T DE 60006362 T DE60006362 T DE 60006362T DE 60006362 D1 DE60006362 D1 DE 60006362D1
- Authority
- DE
- Germany
- Prior art keywords
- pellets
- pharmaceutically acceptable
- pseudoephedrine
- loratadine
- release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR19990005873 | 1999-02-23 | ||
KR9905873 | 1999-02-23 | ||
PCT/KR2000/000130 WO2000050015A1 (en) | 1999-02-23 | 2000-02-18 | Pharmaceutical capsule compositions containing loratadine and pseudoephedrine |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60006362D1 true DE60006362D1 (de) | 2003-12-11 |
DE60006362T2 DE60006362T2 (de) | 2004-08-26 |
Family
ID=19574799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60006362T Expired - Fee Related DE60006362T2 (de) | 1999-02-23 | 2000-02-18 | Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen |
Country Status (10)
Country | Link |
---|---|
US (1) | US6251427B1 (de) |
EP (1) | EP1154762B1 (de) |
JP (1) | JP3645816B2 (de) |
CN (1) | CN1161112C (de) |
AT (1) | ATE253354T1 (de) |
AU (1) | AU2697100A (de) |
DE (1) | DE60006362T2 (de) |
ES (1) | ES2204517T3 (de) |
HK (1) | HK1043945B (de) |
WO (1) | WO2000050015A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6506783B1 (en) * | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
US6555139B2 (en) | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
WO2001021161A2 (en) * | 1999-09-21 | 2001-03-29 | Schering Corporation | Use of desloratadine for treating allergic and inflammatory conditions |
MXPA03011705A (es) * | 2001-06-20 | 2004-03-19 | Schering Corp | Antihistaminas para el tratamiento de congestion nasal y obstruccion nasal. |
FR2830447B1 (fr) * | 2001-10-09 | 2004-04-16 | Flamel Tech Sa | Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques |
PT1492511E (pt) | 2002-04-09 | 2009-04-09 | Flamel Tech Sa | Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s) |
US20040033257A1 (en) * | 2002-05-30 | 2004-02-19 | Strides Inc. | Pharmaceutical formulation in a drug delivery system and process for preparing the same |
PE20050202A1 (es) * | 2003-05-12 | 2005-05-14 | Dasan Medichen Co Ltd | La composicion farmaceutica de liberacion controlada de pseudoefredina o sus sales |
EP1660047B1 (de) | 2003-08-13 | 2013-11-27 | Biocon Limited | Mikroteilchenförmige fettsäure-salz-festdosis-formulierungen für therapeutische mittel |
PL1667665T3 (pl) * | 2003-09-03 | 2009-06-30 | Pharmaton Sa | Kapsułki zawierające peletki z substancją czynną z różnymi profilami uwalniania |
US20070190125A1 (en) | 2004-03-03 | 2007-08-16 | Constantine Georgiades | Positioning feature for aiding use of film or strip product |
EP2034970B1 (de) | 2006-06-01 | 2012-08-01 | MSD Consumer Care, Inc. | Phenylephrin enthaltende pharmazeutische formulierung mit verzögerter freisetzung |
JP2009538919A (ja) * | 2006-06-01 | 2009-11-12 | シェーリング コーポレイション | フェニレフリンのパルス化放出処方物および薬学的組成物 |
JP2009542669A (ja) * | 2006-06-30 | 2009-12-03 | テバ ファーマシューティカル インダストリーズ リミティド | ピペリジノアルカノールと充血除去剤の組み合わせを含んで成る医薬組成物 |
JP5668317B2 (ja) * | 2009-04-24 | 2015-02-12 | 大正製薬株式会社 | プソイドエフェドリン含有製剤粒子 |
US20110218209A1 (en) * | 2010-03-06 | 2011-09-08 | Paul Daniel Yered | Nutrient delievry drug composition |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2738303A (en) * | 1952-07-18 | 1956-03-13 | Smith Kline French Lab | Sympathomimetic preparation |
US4173626A (en) * | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
US5314697A (en) * | 1992-10-23 | 1994-05-24 | Schering Corporation | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
KR960006917A (ko) | 1994-08-13 | 1996-03-22 | 김태훈 | 테르페나딘과-염산슈도에페드린 복합 펠렛(pellet) 조성물 |
PL333056A1 (en) * | 1996-10-31 | 1999-11-08 | Schering Corp | Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug |
US5840329A (en) * | 1997-05-15 | 1998-11-24 | Bioadvances Llc | Pulsatile drug delivery system |
-
2000
- 2000-02-18 AT AT00905431T patent/ATE253354T1/de not_active IP Right Cessation
- 2000-02-18 DE DE60006362T patent/DE60006362T2/de not_active Expired - Fee Related
- 2000-02-18 EP EP00905431A patent/EP1154762B1/de not_active Expired - Lifetime
- 2000-02-18 CN CNB008041857A patent/CN1161112C/zh not_active Expired - Fee Related
- 2000-02-18 ES ES00905431T patent/ES2204517T3/es not_active Expired - Lifetime
- 2000-02-18 AU AU26971/00A patent/AU2697100A/en not_active Abandoned
- 2000-02-18 JP JP2000600627A patent/JP3645816B2/ja not_active Expired - Fee Related
- 2000-02-18 WO PCT/KR2000/000130 patent/WO2000050015A1/en active IP Right Grant
- 2000-02-22 US US09/507,995 patent/US6251427B1/en not_active Expired - Fee Related
-
2002
- 2002-07-24 HK HK02105460.8A patent/HK1043945B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1161112C (zh) | 2004-08-11 |
EP1154762B1 (de) | 2003-11-05 |
AU2697100A (en) | 2000-09-14 |
DE60006362T2 (de) | 2004-08-26 |
JP2002537323A (ja) | 2002-11-05 |
US6251427B1 (en) | 2001-06-26 |
ATE253354T1 (de) | 2003-11-15 |
HK1043945B (zh) | 2005-02-08 |
WO2000050015A1 (en) | 2000-08-31 |
EP1154762A1 (de) | 2001-11-21 |
ES2204517T3 (es) | 2004-05-01 |
CN1341014A (zh) | 2002-03-20 |
JP3645816B2 (ja) | 2005-05-11 |
HK1043945A1 (en) | 2002-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE253354T1 (de) | Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen | |
DK0797435T3 (da) | Matrice til kontrolleret frigivelse af lægemidler | |
IL111647A (en) | Pharmaceutical compositions comprising microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles and their preparation | |
UA88056C2 (uk) | Дозована форма оксикодону, що вводиться один раз на день | |
DK0939626T3 (da) | Galenisk form til forlænget frigivelse af milnacipran | |
DK0923934T3 (da) | Modified release-matrixformulering af cefaclor og cephalexin | |
CA2346001A1 (en) | Controlled release nanoparticulate compositions | |
DE69331906T2 (de) | Granulierte pharmazeutische zusammensetzung | |
ES512393A0 (es) | "un procedimiento para preparar una composicion farmaceutica de liberacion mantenida a base de indoramin micronizado". | |
CA2133503A1 (en) | Orally administrable opioid formulations having extended duration of effect | |
WO2004108162A3 (en) | Controlled release pharmaceutical composition | |
ES2051782T3 (es) | Una composicion farmaceutica de liberacion lenta. | |
ATE424810T1 (de) | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung | |
CZ225596A3 (en) | Film-coated tablets of paracetamol and domperidon | |
CA2383212A1 (en) | Controlled release oral dosage suitable for oral administration | |
DE60035579D1 (de) | Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme | |
JP2004522780A5 (de) | ||
IT1293835B1 (it) | Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione | |
MX9710413A (es) | Formulaciones de liberacion controlada para medicamentos pobremente solubles. | |
RU98111607A (ru) | Фармацевтические готовые формы |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |